Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY)

233 filings reported holding RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 162,665,545 shares of 171,717,172 outstanding shares and own 94.73% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (27,904,963 shares), BlackRock, Inc. (14,478,798 shares), VANGUARD GROUP INC (12,105,420 shares), Point72 Asset Management, L.P. (10,827,067 shares), Casdin Capital, LLC (9,098,574 shares), TANG CAPITAL MANAGEMENT LLC (8,068,058 shares), Bellevue Group AG (7,377,292 shares), STATE STREET CORP (5,159,192 shares), JPMORGAN CHASE & CO (4,909,771 shares), and Nextech Invest, Ltd. (3,846,409 shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.